Archives

by in
Entry Author Date Location
East Coast Life Sciences Roundup: Ariad, Pfizer, Cubist, More 01/25/13 Boston
LinkedIn: The Quiet Force Transforming Biotech & Pharma 11/05/12 National
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Kala, ImmunoGen, Boring Biotech, & More Boston Life Sciences News 07/13/12 Boston
The Best Boring Companies in Biotech 07/09/12 National
Kineta, Playing for Bunt Singles, Builds a Biotech Company Without VC Bucks 06/06/12 Seattle
Antibiotic R&D is in Trouble: Here’s One Way to Fix It 05/07/12 National
New England’s Emerging Biotech Stars: An Xconomy Forum In Pictures 04/09/12 Boston
Mnemosyne, Hydra, On-Q-ity, & More New England Life Sciences News 02/17/12 Boston
Hydra Makes Progress in Pain With First Trial and New Partnership 02/15/12 Boston
AvidBiotics Sees New Angle for Personalized Medicine in Antibiotics 02/01/12 San Francisco
Forma Cuts $65M Deal With Boehringer Ingelheim to Discover Cancer Drugs 01/05/12 Boston
New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News 10/28/11 Boston
Hadapt Gets Series A, Cisco Buys BNI, Cubist Acquisition of Adolor Valued at $415M, & More Boston-Area Deals News 10/26/11 Boston
Genentech Scoops Up Tumor-Starving Drug Program From Forma Therapeutics In Rare Deal 06/27/11 Boston
Optimer Cruises Into Memorable Memorial Day Weekend, Awaiting FDA Word on Antibiotic 05/27/11 San Diego
Nestlé Acquires Prometheus, Trius Raises $30M in Private Placement, Canaan’s Bloch Discusses Advanced BioHealing Deal, & More San Diego Life Sciences News 05/26/11 San Diego
Westphal Leaving Glaxo, Cubist Settles Patent Litigation with Teva, BSX Buys S.I., & More Boston-Area Life Sciences News 04/08/11 Boston
Optimer Inks Potential $47.5M-Plus Deal with Cubist to Help Sell Antibiotic 04/06/11 San Diego
Cubist Settles Key Litigation 04/05/11 Boston
Biotechies Need to Get Serious About Antibiotics, Where There is Money to Be Made 04/04/11 National
Forma, After Building Cancer Drug Discovery Engine, Makes First Big Bet on Starving Tumors 03/10/11 Boston
Roche Dumps RNAi, Sends Shock Waves Through Alnylam, Tekmira 11/17/10 National
ATyr Pharma Pockets $23M to Create New Class of Protein Drugs, and New Targets 10/26/10 San Diego
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News 10/22/10 Boston
Cubist Prices $400M Notes Offering 10/20/10 Boston
AvidBiotics Creates Novel Proteins that Kill Bacteria on the Farm, in the Lab, in the Body 09/21/10 San Francisco
Stealthy Mercator, Founded by Biogen Idec Veterans, Raises $2M to Attack Cancer 08/11/10 Boston
Clinical Data Seeks to Challenge Lilly, Pfizer in Antidepressant Market 05/11/10 Boston
The Vertex Alumni: Where Are They Now? 04/29/10 Boston
Page 2 of 4 « previous page · next page »